Antiphospholipid syndrome

International Archives of Allergy and Immunology

Volumn 123, Issue 1, 2000, Pages 67-76

  Gromnica Ihle, Erika ^a   Schossler W ^b  

^a Medical Center for Rheumatology   (Germany)

^b IMTEC Immundiagnostika GmbH   (Germany)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Hughes' syndrome; Recurrent abortions; Thromboses

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; AZATHIOPRINE; CALCIUM; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; CHLOROQUINE; COLECALCIFEROL; CORTICOSTEROID; DANAZOL; DAPSONE; ESTROGEN; HEPARIN; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PREDNISONE; WARFARIN;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FIBRINOLYTIC THERAPY; HUMAN; IMMUNOPATHOGENESIS; LABORATORY DIAGNOSIS; OSTEOPOROSIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; SYNDROME DELINEATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; TISSUE SPECIFICITY;

EID: 0342735258     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024425     Document Type: Review

References (48)

1. Hughes GRV: Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983;187:1088-1089.
2. Gharavi AE, Wilson WA: The syndrome of thrombosis, thrombocytopenia and recurrent abortions associated with antiphospholipid antibodies: Hughes syndrome. Lupus 1996;5: 343-344.
3. Conley CL, Hartmann RC: A haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematodes. J Clin Invest 1952;31:621-622.
4. Moore JE, Mohre CF: Biologically false-positive serological tests for syphilis. Type, incidence, and cause. JAMA 1952;150:467-473.
5. Bowie WEF, Thompson JH, Pascuzzi CA, Owen GA: Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963;62:416-430.
6. Feinstein DI, Rapaport SI: Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972;1:75-95.
7. Nilsson IM, Astedt B, Hedner V, Berezin D: Intrauterine death and circulating anticoagulant (antithromboplastin). Acta Med Scand 1975;197:153-159.
8. Thiagarajan P, Shapiro SS, DeMarco L: Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity: Mechanisms of a lupus anticoagulant. J Clin Invest 1980;66:397-405.
9. Harris EN, Gharavi AE, Boyle ML, et al: Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;ii: 1211-1214.
10. Loizou S, McCrea JD, Rudge AC, et al: Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results. Clin Exp Immunol 1985;62:738-742.
11. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesmann PJ, Barbui T, Zwaal RF, Bevers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-1547.
12. 2-Glycoprotein 1. Proc Natl Acad Sci USA 1990; 87:4120-4124.
13. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T: Anticardiolipin co-factor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-178.
14. Gharavi AE, Koike T, Wilson WA: Classification Criteria Workshop on Antiphospholipid Syndrome, Sapporo 1998.
15. Harris EN: Antiphospholipid syndrome; in Klippel JH, Dieppe PA: Rheumatology, ed 2, London, Mosby, 1998.
16. Piette JC: 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: A 'mission impossible'? Lupus 1996;5: 354-363.
17. 2-GPI recognized by anticardiolipin antibodies. Lupus 1998;7(suppl 2):14-17.
18. Ordi-Ros J, Selva-O'Callaghan A, Vilardell-Tarrés M: Thrombotic manifestations in the antiphospholipid syndrome; in Asherson RA, Cervera R, Piette JC, Shoenfeld Y (eds): The Antiphospholipid Syndrome. Boca Raton, CRC Press, 1996, pp 107-115.
19. Khamashta MA: Clinical features and outcome of patients with aPL syndrome: A 10-year follow-up study. 57th Annual Meeting American College of Rheumatology, San Antonio 1993.
20. Asherson RA: The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-512.
21. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR: Outcome of treated pregnancies in women with anti-phospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992;80:614-620.
22. Lima F, Khamashta MA, Buchanan NM, Kerslake S, Hung BJ, Hughes GR: A study of sixty pregnancies in patients with the anti-phospholipid syndrome. Clin Exp Rheumatol 1996;14: 131-136.
23. Welsch S, Branch DW: Anti-phospholipid syndrome in pregnancy. Rheum Dis Clin North Am 1997;23:71-84.
24. Salafia CM, Parke AL: Placental pathology in systemic lupus erythematosus and phospholipid antibody syndrome. Rheum Dis Clin North Am 1997;23:85-97.
25. Italian Registry of Antiphospholipid Antibodies (IR-APA): Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): First report from the Italian Registry, Haematologic 1993;78: 313-318.
26. Levine SR, Brey RL: Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996;5:347-353.
27. Vaarala O, Alfthan G, Jauhiainen M, et al: Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 341:923-925.
28. Exner T, Triplett D, Taberner D, Machin SJ: Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thromb Haemost 1991;65:320-322.
29. Triplett DA: Assay for detection of antiphospholipid antibodies. Lupus 1994;3:281-287.
30. Triplett DA: Many faces of lupus anticoagulants. Lupus 1998;suppl 2:18-22.
31. Stewart MW, Etches WS, Russell AS, Percy JS, Johnston CA, Chew CK, Gordon PA: Detection of antiphospholipid antibodies by flow cytometry: Rapid detection of antibody isotype and phospholipid specificity. Thromb Haemostas 1993;70:603-607.
32. Faure M, Coulon-Morelec M: Entre la structure chimique du cardiolipide et son activité sérologique. Conservation du cardiolipide. Ann Inst Pasteur Immunol 1963;104:246-250.
33. Inoue K, Nojima S: Immunochemical studies of phospholipids. IV. The reactivities of antisera against natural cardiolipin and synthetic cardiolipin analogues-containing antigens. Chem Phys Lipids 1969;3:70-74.
34. Franz J: Dissertation, Humboldt University, Berlin 1992.
35. Rauch J, Janoff AS: The nature of antiphospholipid antibodies. J Rheumatol 1992;19: 1782-1785.
36. Koike T, Seuishi M, Funaki M, et al: Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984;56:193-199.
37. Binder WL: The anticardiolipin ELISA test. Am Clin Lab 1992;11:24-25.
38. Harris EN, Charavi AE, Patel SP, Hughes GRV: Evaluation of the anticardiolipin antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68: 215-219.
39. Harris EN: The Second International Anticardiolipins Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94: 476-480.
40. Schoessler W: Zur Bestimmung der Nachweisgrenze im Enzymimmunoassay. Z Med Lab Diagn 1990;31:349-350.
41. 2-glycoprotein I structure altered by interaction with an oxygen-modified solid phase surface. J Exp Med 1994;179:457-461.
42. 2-glycoprotein I antibodies. Lupus 1998; suppl 2:98-102.
43. Piette JC, Wechsler B, Frances C, Papo T, Godeau P: Exclusion criteria for primary antiphospholipid syndrome. J Rheumatol 1993;20: 1802-1804.
44. Khamashta MA: Management of thrombosis in the antiphospholipid syndrome. Lupus 1996;5:463-466.
45. Khamashta MA: Management of thrombosis and pregnancy loss in the antiphospholipid syndrome. Lupus 1998;suppl 2:162-165.
46. Clark AL, Gall SA: Clinical uses of intravenous immunoglobulin in pregnancy. Am J Obstet Gynecol 1997;176:241-253.
47. Khamashta MA, Hughes GRV: Das Antiphospholipid-Syndrom. Rheumatol Europa 1994; 23:23-26.
48. Wilson WA, Gharavi AE, Koike T et al.: International consensus statement on preliminary classification criteria for definite Antiphospholid syndrome. Arthritis Rheum 1999;42: 1309-1311.